U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Cefditoren Pivoxil – Oral products
  1. Development Resources

Cefditoren Pivoxil – Oral products

Additional FDA-identified interpretive criteria

  Minimum Inhibitory
Concentrations
(mcg/mL)
Disk Diffusion
(zone diameter in mm)
Pathogen S I R S I R
Streptococcus pneumoniae ≤0.125 0.25 >0.50 - - -
Haemophilus influenzae and
parainfluenzae
≤0.125 0.25 >0.50 - - -
Streptococcus spp β-
Hemolytic Group
≤0.125 - - - - -

S = Susceptible; I = Intermediate; R = Resistant

Back to Top